Article
Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs
15 Apr 2007
Abstract excerpt
PURPOSE: Variations in biotransformation and elimination of microtubule-binding drugs are a major cause of unpredictable side effects during cancer therapy. Because the orphan receptor, pregnenolone X-receptor (PXR), coordinately regulates the expression of paclitaxel metabolizing and transport enzymes, controlling this process could improve therapeutic outcome. EXPERIMENTAL DESIGN: In vitro RNA-, protein-, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
